Neumora Therapeutics (NMRA) Earnings Date, Estimates & Call Transcripts $1.64 +0.01 (+0.61%) Closing price 04:00 PM EasternExtended Trading$1.63 -0.01 (-0.55%) As of 04:19 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Neumora Therapeutics Earnings Summary Neumora Therapeutics released Q2 2025 earnings on August 6, 2025, reporting an EPS of -$0.33, which beat analysts' consensus estimates of -$0.38 by $0.05. With a trailing EPS of -$1.57, Neumora Therapeutics' earnings are expected to grow next year, from ($1.61) to ($1.54) per share. Latest Q2 Earnings DateAug. 6EstimatedConsensus EPS (Aug. 6) -$0.38 Actual EPS (Aug. 6) -$0.33 Beat By $0.05 Q2 2025 Earnings ResourcesQ2 2025 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Quarterly Report (10-Q)Powered by Get Neumora Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Neumora Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataNMRA Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Neumora Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20252-$0.46-$0.37-$0.42Q2 20252-$0.44-$0.35-$0.40Q3 20252-$0.39-$0.28-$0.34Q4 20252-$0.40-$0.29-$0.35 FY 2025 8 -$1.69 -$1.29 -$1.49 Q1 20262-$0.44-$0.27-$0.36Q2 20262-$0.44-$0.20-$0.32Q3 20262-$0.37-$0.21-$0.29Q4 20262-$0.38-$0.22-$0.30 Neumora Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails8/6/2025Q2 2025-$0.38-$0.33+$0.05-$0.33--5/12/2025Q1 2025-$0.40-$0.42 -$0.02-$0.42--3/6/2025Q4 2024-$0.46-$0.37+$0.09-$0.37--11/12/2024Q3 2024-$0.39-$0.45 -$0.06-$0.45--8/6/2024Q2 2024-$0.37-$0.37--$0.37--5/7/2024Q1 2024-$0.34-$0.34--$0.34--3/7/2024Q4 2023-$0.76-$0.71+$0.05-$0.71--11/1/2023Q3 2023-$0.35-$1.14 -$0.79-$1.14-- Neumora Therapeutics Earnings - Frequently Asked Questions When did Neumora Therapeutics announce their last quarterly earnings? Neumora Therapeutics (NASDAQ:NMRA) last announced its quarterly earning data on Wednesday, August 6, 2025. Learn more on NMRA's earnings history. Did Neumora Therapeutics beat their earnings estimates last quarter? In the previous quarter, Neumora Therapeutics (NASDAQ:NMRA) reported ($0.33) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.38) by $0.05. Learn more on analysts' earnings estimate vs. NMRA's actual earnings. How can I listen to Neumora Therapeutics' earnings conference call? The conference call for Neumora Therapeutics' latest earnings report can be listened to online. Listen to Conference Call How can I read Neumora Therapeutics' conference call transcript? The conference call transcript for Neumora Therapeutics' latest earnings report can be read online. Read Transcript How much profit does Neumora Therapeutics generate each year? Neumora Therapeutics (NASDAQ:NMRA) has a recorded net income of -$243.79 million. NMRA has generated -$1.57 earnings per share over the last four quarters. What is Neumora Therapeutics' EPS forecast for next year? Neumora Therapeutics' earnings are expected to grow from ($1.61) per share to ($1.54) per share in the next year. More Earnings Resources from MarketBeat Related Companies Structure Therapeutics Earnings Spyre Therapeutics Earnings Akebia Therapeutics Earnings Pharming Group Earnings Cronos Group Earnings Trevi Therapeutics Earnings Enliven Therapeutics Earnings Zymeworks Earnings Upstream Bio Earnings Mineralys Therapeutics Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Green Dot's 30% Rally: Turnaround Takes Off on Explosive EarningsElbit Systems Jumps on Record Earnings and a $1.6B ContractBrinker Serves Up Earnings Beat, Sidesteps Cost PressuresWhy BigBear.ai Stock's Dip on Earnings Can Be an Opportunity CrowdStrike Faces Valuation Test Before Key Earnings ReportPost-Earnings, How Does D-Wave Stack Up Against Quantum Rivals?Why SoundHound AI's Earnings Show the Stock Can Move Higher This page (NASDAQ:NMRA) was last updated on 8/18/2025 by MarketBeat.com Staff From Our PartnersWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredThe stealth altcoin the financial world is underestimatingThis DeFi project could soar next When altcoin season fully kicks in—which the data suggests is happening R...Crypto 101 Media | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredBut this $20 American company could control the secretThe "Impossible" Chip That Runs on Pure Light Google's quantum computer shocked the world... but China DEMO...The Oxford Club | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredGENIUS Act: Cancel Your Money?They said digital dollars were off the table. But with the GENIUS Act now federal law, private corporations—no...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neumora Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Neumora Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access